| Original language | English |
|---|---|
| Pages (from-to) | 2362 - 2363 |
| Number of pages | 2 |
| Journal | Transfusion |
| Volume | 54 |
| Issue number | 9 |
| DOIs | |
| Publication status | Published - 2014 |
Cite this
@article{3dabe19b36a34117a8e2542a88d31852,
title = "N-Acetylcysteine for thrombotic thrombocytopenic purpura: Is a von Willebrand factor-inhibitory dose feasible in vivo?",
author = "Jake Shortt and Stephen Opat and Wood, {Erica Michelle}",
year = "2014",
doi = "10.1111/trf.12787",
language = "English",
volume = "54",
pages = "2362 -- 2363",
journal = "Transfusion",
issn = "0041-1132",
publisher = "Wiley-Blackwell",
number = "9",
}
N-Acetylcysteine for thrombotic thrombocytopenic purpura: Is a von Willebrand factor-inhibitory dose feasible in vivo? / Shortt, Jake; Opat, Stephen; Wood, Erica Michelle.
In: Transfusion, Vol. 54, No. 9, 2014, p. 2362 - 2363.Research output: Contribution to journal › Letter › Other
TY - JOUR
T1 - N-Acetylcysteine for thrombotic thrombocytopenic purpura: Is a von Willebrand factor-inhibitory dose feasible in vivo?
AU - Shortt, Jake
AU - Opat, Stephen
AU - Wood, Erica Michelle
PY - 2014
Y1 - 2014
UR - http://onlinelibrary.wiley.com.ezproxy.lib.monash.edu.au/doi/10.1111/trf.12787/abstract
U2 - 10.1111/trf.12787
DO - 10.1111/trf.12787
M3 - Letter
VL - 54
SP - 2362
EP - 2363
JO - Transfusion
JF - Transfusion
SN - 0041-1132
IS - 9
ER -